查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930108

全球蛋白質體學市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034）

Proteomics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 151 Pages | 商品交期: 請詢問到貨日

價格

蛋白質體學市場成長驅動因素

受生命科學研究投資增加、個人化醫療需求成長以及蛋白質分析技術快速發展的推動，全球蛋白質體學市場正經歷強勁且持續的成長。根據 Fortune Business Insights 的數據顯示，2025 年蛋白質體學市場規模為 419.7 億美元，預計 2026 年將達到 469.7 億美元，2034 年將達到 1,256.4 億美元，預測期內複合年增長率 (CAGR) 為 13.09%。北美地區在 2025 年佔市場主導地位，市佔率達 43.75%。這得歸功於其強大的研發基礎設施和先進蛋白質體學技術的高普及率。

蛋白質體學是指對在生物體的結構、功能和調控中發揮關鍵作用的蛋白質進行大規模研究。蛋白質組代表細胞、組織或生物體表達的所有蛋白質的集合，對其進行分析對於理解疾病機制、識別生物標記和支持藥物研發至關重要。

市場動態

全球對蛋白質體學研究的濃厚興趣是推動該市場發展的主要因素。研究人員正日益深入地探索人類蛋白質組，以識別疾病生物標記、分析蛋白質相互作用並發現新的藥物標靶。精準醫療和個人化醫療的日益普及進一步加速了蛋白質體學的應用，因為蛋白質水平的洞察能夠幫助臨床醫生預測患者對特定療法的反應並制定標靶治療策略。

此外，不斷增長的公共和私人投資也推動了蛋白質體學平台和工作流程的創新。 例如，Syncell 於 2024 年 12 月獲得 1,500 萬美元 A 輪融資，用於拓展其太空蛋白質體學和蛋白質純化技術的商業化應用，這表明投資者對該領域的信心日益增強。

然而，市場面臨一些技術限制，在一定程度上限制了成長。蛋白質組高度複雜且動態變化，蛋白質會經歷各種翻譯後修飾，並以多種亞型存在。檢測和定量高豐度和低豐度蛋白質仍然具有挑戰性，需要先進的儀器和複雜的數據分析演算法。這種複雜性增加了成本，並限制了大樣本研究的可擴展性。

機會與挑戰

個人化醫療的興起為蛋白質體學市場帶來了巨大的成長機會。透過分析個別蛋白質譜，蛋白質體學能夠開發個人化療法，改善疾病預後，並提高治療效果。 預計這一趨勢將推動製藥和生技公司進一步投資。

同時，資料複雜性構成了一項重大挑戰。蛋白質體學產生大量且複雜的資料集，其解讀需要先進的計算工具。將蛋白質組學數據與基因組學和轉錄組學數據整合對於獲得全面的生物學見解至關重要，但這種整合在技術上具有挑戰性，且需要大量資源。

市場趨勢

技術進步是塑造蛋白質體學市場的關鍵趨勢。質譜技術的創新、通量的提高、靈敏度的增強以及單細胞蛋白質體學的出現正在拓展其應用領域。 2025年6月，賽默飛世爾科技在ASMS大會上發表了先進的質譜解決方案，再次強調了創新對於推動市場成長的重要性。

細分市場分析

依產品類型劃分，產品佔市場主導地位，預計到 2026 年將保持 55.42% 的市場佔有率，這主要得益於研發領域對設備和耗材的廣泛應用。同時，由於對生物資訊學和外包蛋白質組學分析的需求不斷增長，服務預計將保持穩定成長。

依技術類型劃分，質譜技術預計將引領市場，到 2026 年將佔 35.55% 的市場佔有率，這主要得益於其在藥物發現、生物標記鑑定和臨床研究中的廣泛應用。

依應用領域劃分，藥物發現預計將在 2024 年佔市場首位，這主要得益於研發活動的增加和對標靶治療需求的增長。 依最終用戶劃分，預計到 2026 年，製藥和生物技術公司將佔市場主導地位，市場佔有率高達 69.56%，這反映了蛋白質組學在治療藥物開發中的廣泛應用。

區域展望

預計到 2025 年，北美市場規模將達到 183.6 億美元，主要得益於強勁的投資、先進的技術以及對個人化醫療的重視。美國仍將是最大的貢獻者，到 2026 年市場規模將達到 187.6 億美元。歐洲市場由於研發舉措的支持而保持穩步增長，而亞太地區預計將實現最快增長，這得益於政府資金投入、基礎設施建設以及中國、印度和日本等國家日益增長的應用。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 蛋白質體學技術進展
  • 主要國家和地區的監管狀況
  • 關鍵產業趨勢：併購、業務合作等
  • 主要公司的新產品發布

第五章 全球蛋白質體學市場分析：洞察與預測 （2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 產品
      • 儀器
      • 耗材
    • 服務
      • 生物資訊學
      • 核心服務
  • 市場分析、洞察與預測：依技術劃分
    • 質譜分析
    • 色譜分析
    • 電泳分析
    • X射線晶體繞射分析
    • 蛋白質顯微鏡陣列分析
    • 其他
  • 市場分析、洞察與預測：依應用領域劃分
    • 藥物發現
    • 臨床診斷
    • 其他
  • 市場分析、洞察與預測：以最終用戶劃分用戶
    • 製藥和生技公司
    • 研究和學術機構
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美蛋白質體學市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲蛋白質體學市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區蛋白質體學市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲蛋白質體學市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區美國

第十章：中東與非洲蛋白質體學市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • Agilent Technologies Inc.
    • Thermo Fisher Scientific Inc.
    • Bio Rad Laboratories Inc.
    • Illumina Inc.
    • QIAGEN
    • Shimadzu Corporation
    • Promega Corporation
    • Danaher
    • Waters Corporation
    • Bruker
Product Code: FBI106940

Growth Factors of proteomics Market

The global proteomics market is experiencing strong and sustained growth, driven by rising investments in life science research, increasing demand for personalized medicine, and rapid technological advancements in protein analysis. According to Fortune Business Insights, the proteomics market was valued at USD 41.97 billion in 2025. The market is projected to be worth USD 46.97 billion in 2026 and is expected to reach USD 125.64 billion by 2034, growing at a CAGR of 13.09% during the forecast period. In 2025, North America dominated the market with a share of 43.75%, supported by strong R&D infrastructure and high adoption of advanced proteomics technologies.

Proteomics refers to the large-scale study of proteins, which play a critical role in the structure, function, and regulation of living organisms. The proteome represents the complete set of proteins expressed by a cell, tissue, or organism, and its analysis is essential for understanding disease mechanisms, identifying biomarkers, and supporting drug discovery efforts.

Market Dynamics

The market is primarily driven by the strong global focus on proteomics research. Researchers are increasingly studying the human proteome to identify disease biomarkers, analyze protein interactions, and discover novel drug targets. The growing emphasis on precision and personalized medicine further accelerates the adoption of proteomics, as protein-level insights allow clinicians to predict patient responses to specific therapies and design targeted treatment strategies.

In addition, rising public and private investments are supporting innovation in proteomics platforms and workflows. For example, in December 2024, Syncell secured USD 15 million in Series A funding to expand commercialization of its spatial proteomics and protein purification technologies, highlighting increasing investor confidence in this field.

However, the market faces technical limitations that restrain growth to some extent. The proteome is highly complex and dynamic, with proteins undergoing various post-translational modifications and existing in multiple isoforms. Detecting and quantifying both high- and low-abundance proteins remains challenging, requiring advanced instruments and sophisticated data analysis algorithms. These complexities increase costs and limit scalability for large sample studies.

Opportunities and Challenges

The shifting focus toward personalized medicine presents a major growth opportunity for the proteomics market. By analyzing individual protein profiles, proteomics enables the development of tailored therapies, improved disease prognosis, and better treatment outcomes. This trend is expected to drive further investments from pharmaceutical and biotechnology companies.

At the same time, data complexity poses a significant challenge. Proteomics generates large and complex datasets that require advanced computational tools for interpretation. Integrating proteomics data with genomics and transcriptomics is essential for comprehensive biological insights, but this integration is technically demanding and resource-intensive.

Market Trends

Technological advancements are a key trend shaping the proteomics market. Innovations in mass spectrometry, increased throughput, enhanced sensitivity, and the emergence of single-cell proteomics are expanding application areas. In June 2025, Thermo Fisher Scientific introduced advanced mass spectrometry solutions at the ASMS Conference, reinforcing the importance of innovation in driving market growth.

Segmentation Insights

By offering, products dominate the market and are projected to hold a 55.42% share in 2026, driven by widespread adoption of instruments and consumables in R&D. Services are expected to grow steadily due to rising demand for bioinformatics and outsourced proteomics analysis.

By technology, mass spectrometry leads the market with a projected 35.55% share in 2026, owing to its extensive use in drug discovery, biomarker identification, and clinical research.

In terms of application, drug discovery held the leading position in 2024, supported by increasing R&D activities and demand for targeted therapies. By end user, pharmaceutical and biotechnology companies dominated the market with a 69.56% share in 2026, reflecting heavy utilization of proteomics in therapeutic development.

Regional Outlook

In 2025, North America generated USD 18.36 billion, driven by strong investments, advanced technologies, and a focus on personalized medicine. The U.S. remains the largest contributor and is expected to reach USD 18.76 billion by 2026. Europe is showing steady growth due to supportive research initiatives, while Asia Pacific is expected to witness the fastest growth, supported by government funding, infrastructure development, and rising adoption in countries such as China, India, and Japan.

Conclusion

The global proteomics market is set for significant expansion, growing from USD 41.97 billion in 2025 to USD 125.64 billion by 2034. Strong research focus, technological advancements, and increasing adoption in personalized medicine and drug discovery are driving this growth. Although technical and data-related challenges persist, continuous innovation and rising investments are expected to strengthen the market outlook, making proteomics a cornerstone technology in modern life sciences and healthcare.

Segmentation By Offering

  • Products
    • Instruments
    • Consumables
  • Services
    • Bioinformatics
    • Core Services

By Technology

  • Mass Spectrometry
  • Chromatography
  • Electrophoresis
  • X-Ray Crystallography
  • Protein Microarray
  • Others

By Application

  • Drug Discovery
  • Clinical Diagnostics
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Others

By Region

  • North America (By Offering, Technology, Application, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Offering, Technology, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Technology, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Technology, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Technology, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Proteomics
  • 4.2. Regulatory Scenario, By Key Countries/Regions
  • 4.3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
  • 4.4. New Product Launches, By Key Players

5. Global Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Products
      • 5.1.1.1. Instruments
      • 5.1.1.2. Consumables
    • 5.1.2. Services
      • 5.1.2.1. Bioinformatics
      • 5.1.2.2. Core Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Mass Spectrometry
    • 5.2.2. Chromatography
    • 5.2.3. Electrophoresis
    • 5.2.4. X-Ray Crystallography
    • 5.2.5. Protein Microarray
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Drug Discovery
    • 5.3.2. Clinical Diagnostics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. Research & Academic Institutes
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Products
      • 6.1.1.1. Instruments
      • 6.1.1.2. Consumables
    • 6.1.2. Services
      • 6.1.2.1. Bioinformatics
      • 6.1.2.2. Core Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Mass Spectrometry
    • 6.2.2. Chromatography
    • 6.2.3. Electrophoresis
    • 6.2.4. X-Ray Crystallography
    • 6.2.5. Protein Microarray
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Drug Discovery
    • 6.3.2. Clinical Diagnostics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. Research & Academic Institutes
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Products
      • 7.1.1.1. Instruments
      • 7.1.1.2. Consumables
    • 7.1.2. Services
      • 7.1.2.1. Bioinformatics
      • 7.1.2.2. Core Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Mass Spectrometry
    • 7.2.2. Chromatography
    • 7.2.3. Electrophoresis
    • 7.2.4. X-Ray Crystallography
    • 7.2.5. Protein Microarray
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Drug Discovery
    • 7.3.2. Clinical Diagnostics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. Research & Academic Institutes
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Products
      • 8.1.1.1. Instruments
      • 8.1.1.2. Consumables
    • 8.1.2. Services
      • 8.1.2.1. Bioinformatics
      • 8.1.2.2. Core Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Mass Spectrometry
    • 8.2.2. Chromatography
    • 8.2.3. Electrophoresis
    • 8.2.4. X-Ray Crystallography
    • 8.2.5. Protein Microarray
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Drug Discovery
    • 8.3.2. Clinical Diagnostics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Research & Academic Institutes
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Products
      • 9.1.1.1. Instruments
      • 9.1.1.2. Consumables
    • 9.1.2. Services
      • 9.1.2.1. Bioinformatics
      • 9.1.2.2. Core Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Mass Spectrometry
    • 9.2.2. Chromatography
    • 9.2.3. Electrophoresis
    • 9.2.4. X-Ray Crystallography
    • 9.2.5. Protein Microarray
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Drug Discovery
    • 9.3.2. Clinical Diagnostics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. Research & Academic Institutes
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Products
      • 10.1.1.1. Instruments
      • 10.1.1.2. Consumables
    • 10.1.2. Services
      • 10.1.2.1. Bioinformatics
      • 10.1.2.2. Core Services
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Mass Spectrometry
    • 10.2.2. Chromatography
    • 10.2.3. Electrophoresis
    • 10.2.4. X-Ray Crystallography
    • 10.2.5. Protein Microarray
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Drug Discovery
    • 10.3.2. Clinical Diagnostics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. Research & Academic Institutes
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Agilent Technologies Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Bio Rad Laboratories Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Illumina Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. QIAGEN
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Shimadzu Corporation
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Promega Corporation
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Danaher
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Waters Corporation
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Bruker
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 2: Global Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 3: Global Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 4: Global Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 5: Global Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 6: Global Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Proteomics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 9: North America Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 10: North America Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 11: North America Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 12: North America Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 13: North America Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Proteomics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 16: Europe Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 17: Europe Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 18: Europe Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 19: Europe Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 20: Europe Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Proteomics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 23: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 24: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 25: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 26: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 30: Latin America Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 31: Latin America Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 32: Latin America Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 33: Latin America Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: Latin America Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Proteomics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 37: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 38: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 39: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 40: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 41: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Proteomics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Proteomics Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Proteomics Market Value Share (%), by Technology, 2025 & 2034
  • Figure 4: Global Proteomics Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Proteomics Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Proteomics Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 8: North America Proteomics Market Value Share (%), By Offering, 2025
  • Figure 9: North America Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 10: North America Proteomics Market Value Share (%), by Technology, 2025
  • Figure 11: North America Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 12: North America Proteomics Market Value Share (%), By Application, 2025
  • Figure 13: North America Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Proteomics Market Value Share (%), by End User, 2025
  • Figure 15: North America Proteomics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Proteomics Market Value Share (%), By Country, 2025
  • Figure 17: Europe Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 18: Europe Proteomics Market Value Share (%), By Offering, 2025
  • Figure 19: Europe Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 20: Europe Proteomics Market Value Share (%), by Technology, 2025
  • Figure 21: Europe Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 22: Europe Proteomics Market Value Share (%), By Application, 2025
  • Figure 23: Europe Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Proteomics Market Value Share (%), by End User, 2025
  • Figure 25: Europe Proteomics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Proteomics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 28: Asia Pacific Proteomics Market Value Share (%), By Offering, 2025
  • Figure 29: Asia Pacific Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 30: Asia Pacific Proteomics Market Value Share (%), by Technology, 2025
  • Figure 31: Asia Pacific Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Proteomics Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Proteomics Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Proteomics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Proteomics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 38: Latin America Proteomics Market Value Share (%), By Offering, 2025
  • Figure 39: Latin America Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 40: Latin America Proteomics Market Value Share (%), by Technology, 2025
  • Figure 41: Latin America Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 42: Latin America Proteomics Market Value Share (%), By Application, 2025
  • Figure 43: Latin America Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Proteomics Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Proteomics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Proteomics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 48: Middle East & Africa Proteomics Market Value Share (%), By Offering, 2025
  • Figure 49: Middle East & Africa Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 50: Middle East & Africa Proteomics Market Value Share (%), by Technology, 2025
  • Figure 51: Middle East & Africa Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa Proteomics Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Proteomics Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Proteomics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Proteomics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Proteomics Market Share (%), By Company, 2025